Research 25 May 2016
Examine How Payers Make Reimbursement Decisions
We would like to invite you to download an invaluable webinar about the biggest customer, biopharma companies don’t understand – payers. Rodger Longman from RealEndpoints takes a look at the implications for specialty medicines in areas such as COPD, Multiple Myeloma, Eosinophilic Asthma, Crohn’s Disease, as well as the steps you can take to develop effective clinical, market access, pricing and marketing strategies.
Big Pharma Licensing Trends Report
Datamonitor Healthcare and its sister brand Medtrack have joined forces to bring you a comprehensive analysis of drug-focused licensing deals between 2011 – 2015. Check out our latest infographic which explores some of the key findings from this report.
Rely on timely, in-depth and interactive research of the pharmaceutical and biotechnology industries, with expert analysis that keeps you strategically aligned with developments across a range of key diseases, companies, drugs and strategic trends.
Examine over 2,000 individual drug profiles for comprehensive analysis and forecast assessments of marketed products and pipeline compounds across their full range of indications.
Assess the pipelines, performances, and future prospects of the leading pharma and biotech companies, major generics/biosimilars developers, and emerging players at the forefront of innovation.
Quantify disease prevalence/incidence and patient-population projections across key geographies to quantify unmet need potential, with forecasts based on rigorous data standards and methodologies.
Review the market dynamics of major disease areas and key indications to assess treatment trends, unmet needs, and topical developments, in addition to the pipeline and currently marketed products of key companies.
Evaluate key trends shaping the industry and position your company to respond effectively to factors influencing pricing/reimbursement, competitive dynamics, growth markets, and value chain issues.
"First impressions: outstanding. This is a real quantum leap. For me, Datamonitor used to be mainly a report platform with other services... Now it is a fully integrated database with a nice layout, easy and self-explanatory navigation, with tons of information that's only a mouse-click away... "
Marketing Manager, Lonza
Research 25 May 2016
Research Wire 24 May 2016
Research Wire 23 May 2016
26 May 2016
23 May 2016
18 May 2016
You now have full access to all articles on our site for the next 28 days.